Sign up for updates!
Get news from UC Davis MIND Institute in your inbox.
School of Medicine
David J. Segal to lead Biochemistry and Molecular Medicine
Researcher is known for advances in gene-editing technologies used for research and therapeutic applications for rare diseases
Top Stories
-
General Health NewsOctubure 20, 2025Declaración del Instituto MIND de UC Davis sobre el acetaminofeno y el autismo
El Instituto MIND de UC Davis da a conocer las últimas investigaciones sobre el acetaminofeno y el autismo.
Leer más -
MIND InstituteSEPTEMBER 23, 2025
UC Davis MIND Institute statement on acetaminophen and autism
UC Davis MIND Institute experts share what the science says about autism, acetaminophen and leucovorin.
Read More -
MIND InstituteSEPTEMBER 18, 2025UC Davis scientists pioneer stem cell gene therapy for Angelman syndrome
UC Davis Health researchers are testing a groundbreaking new therapy for the rare neurodevelopmental condition Angelman syndrome.
Read More -
MIND InstituteSEPTEMBER 17, 2025Autistic children more likely to experience persistent gastrointestinal problems
Stomach issues in autistic children are linked to greater challenges with sleep, communication, sensory processing and behavior, finds a study by the UC Davis MIND Institute.
Read More -
MIND InstituteSEPTEMBER 08, 2025Program helps over 800 families navigate resources and services for autism and other conditions
The UC Davis MIND Institute’s Family Navigator Program offers help accessing services, therapies and resources after a diagnosis of autism or another neurodevelopmental condition.
Read More